FRM
IART icon

Fox Run Management’s Integra LifeSciences IART Stock Holding History

Fox Run Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,472
Closed -$892K – 909
2023
Q4 		$892K Buy
+20,472
New +$806K 0.23% 115
2023
Q3 		– Sell
-12,124
Closed -$499K – 827
2023
Q2 		$499K Buy
+12,124
New +$584K 0.14% 287
2023
Q1 		– Sell
-7,619
Closed -$427K – 783
2022
Q4 		$427K Sell
7,619
-311
-4% -$15.8K 0.17% 228
2022
Q3 		$336K Buy
+7,930
New +$406K 0.13% 313
2022
Q1 		– Sell
-5,566
Closed -$373K – 600
2021
Q4 		$373K Buy
+5,566
New +$377K 0.22% 156
2020
Q1 		– Sell
-5,230
Closed -$305K – 236
2019
Q4 		$305K Buy
+5,230
New +$311K 0.25% 191
2019
Q2 		– Sell
-7,286
Closed -$406K – 512
2019
Q1 		$406K Buy
+7,286
New +$371K 0.23% 170
2018
Q2 		– Sell
-8,733
Closed -$483K – 785
2018
Q1 		$483K Buy
8,733
+624
+8% +$32.7K 0.12% 325
2017
Q4 		$388K Buy
+8,109
New +$397K 0.11% 371
2017
Q3 		– Sell
-5,900
Closed -$322K – 759
2017
Q2 		$322K Sell
5,900
-22,100
-79% -$1.06M 0.11% 385
2017
Q1 		$1.18M Buy
+28,000
New +$1.2M 0.48% 7

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fox Run Management's IART Position: Q1 2024 in Review

Fox Run Management sold out of Integra LifeSciences (IART) in Q1 2024, closing a stake of 20,472 shares — an estimated $892K sold.

Fox Run Management first reported a position in IART in Q1 2017 and held it in 11 quarters. The position peaked at $1.18M in Q1 2017. 281 funds tracked by Wall St. Rank hold IART as of Q1 2024.

  • Fox Run Management reported no remaining Integra LifeSciences position as of Q1 2024 after selling out during the quarter.
  • Fox Run Management sold 20,472 Integra LifeSciences shares in Q1 2024, an estimated $892K.
  • Fox Run Management first reported a position in Integra LifeSciences in Q1 2017 and held it in 11 quarters.
  • Fox Run Management's Integra LifeSciences position peaked at $1.18M in Q1 2017.
  • 281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2024.

Based on Fox Run Management's 13F filing for Q1 2024, filed 13 May 2024.